Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

The Hive is open for 2017 applicants

Posted on June 23rd, 2017 by in Pharma R&D

The hive

It’s been over a year since Elsevier first launched The Hive, and we are inspired by the results that we have seen from this venture. Through frequent blog posts and video interviews, we and everyone who followed the project have been able to see the progress made by the four participating companies: Continue reading “The Hive is open for 2017 applicants” »

Broadening the Field of Research While Staying Focused

Posted on June 7th, 2017 by in Pharma R&D

Since joining The Hive, our team at Myelo Therapeutics has had the opportunity to train on and utilize a number of Elsevier’s information solutions, and they have already made a significant impact on our work, whether using Scopus to find collaborators or analyzing chemical structures with Reaxys. Continue reading “Broadening the Field of Research While Staying Focused” »

The Success of Personalized Anti-Cancer Therapies

Posted on January 4th, 2017 by in Pharma R&D

Every day, thousands of cancer patients face difficult choices about their treatment options. For those affected by advanced, stage 4 cancer, the decisions can be particularly painful. Continue reading “The Success of Personalized Anti-Cancer Therapies” »

An Update from Myelo: Expanding Our Team and Evaluating Data

Posted on December 14th, 2016 by in Pharma R&D

The focus of our current non-clinical research at Myelo Therapeutics is to fully elucidate the mode of action for prevention of myelosuppression as well as Myelo001’s antiviral capabilities. But to achieve this goal, it’s important to have highly skilled and motivated personnel within your team. Continue reading “An Update from Myelo: Expanding Our Team and Evaluating Data” »

  1. 1
  2. 2
  3. 3